Jon Freve

Chief Financial Officer at Alentis Therapeutics

Speaker

Jon Freve joined Alentis in 2024 bringing more than 25 years of financial experience in biotech. Prior to Alentis, he served as CFO of Galecto, a NASDAQ-listed clinical-stage biotechnology company with locations in Copenhagen and Boston, where he led the IPO process in 2020. Prior to Galecto, Jon served as CFO and Treasurer of Spring Bank Pharmaceuticals, a NASDAQ-listed clinical-stage biotechnology company in Boston, where he led the IPO process in 2016. Before that, he was at Santaris Pharma in Copenhagen, which was acquired by Roche in 2014.

Jon began his career at the Financial Accounting Standards Board (FASB) and PricewaterhouseCoopers, where he worked in audit and transaction services. Jon has worked on multiple successful initial public offerings, secondary offerings, mergers and acquisitions.

He is a certified public accountant in Massachusetts and holds a bachelor’s degree in Business Administration from the University of Massachusetts Amherst.